Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Astellas submits new prostate cancer drug to EMA

June 28, 2012 Research and Development, Sales and Marketing Astellas, EMA, Medivation, NICE, Zytiga, enzalutamide

Astellas has submitted its investigational prostate cancer drug enzalutamide to the European Medicines Agency. Enzalutamide is a once-daily pill that works …
News

Amylin withheld safety data, says FDA

June 27, 2012 Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly

The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …
News

Roche cuts 1,000 R&D jobs

June 27, 2012 Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …
News
Roche image

Roche’s Perjeta increases survival

June 27, 2012 Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …
News

Steve Bates appointed chief executive of the BioIndustry Association

June 25, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Genzyme, Steve Bates

The BioIndustry Association (BIA) has appointed Steve Bates as its chief executive. Bates has worked both in biotech and the …
Appointment

The European Medicines Group: focused on UK market access

June 25, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMG, NICE, VBP, market access

Maintaining a dialogue with government, NHS organisations and other stakeholder groups is essential for pharma companies in the UK, and …
Feature

Takeda makes changes to organisation

June 22, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda has announced the change of senior leadership and the establishment of a new organisation.Effective from July Masahiro Fujimaki becomes …
Appointment
AstraZeneca image

AstraZeneca buys Ardea Biosciences

June 22, 2012 Research and Development, Sales and Marketing Abbott, Ardea Biosciences, AstraZeneca, Bayer, Humira, Takeda

AstraZeneca has completed its acquisition of US firm Ardea Biosciences in a $1.26 billion deal that it hopes will shore …
News

Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions

June 21, 2012 Manufacturing and Production, Research and Development

Seattle, Wash., and Somerset N.J., (June 20, 2012)  — Frazier Healthcare and Catalent Pharma Solutions, Inc., today announced they have closed …
News
Press release
juliastrakerpress-11

New head of strategic planning for PAN advertising

June 21, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Indigenus, Med Comms, Pan Advertising, appointment

Julia Straker has been appointed head of strategic planning at medical communciations agency PAN Advertising.  Julia joins from TBWA\Paling Walters …
Appointment

Sanofi joins forces with Joslin Diabetes Center

June 21, 2012 Research and Development, Sales and Marketing

Sanofi and the Joslin Diabetes Center have created a new partnership to develop diabetes medicines. The collaboration will focus on …
News

Contract research news in brief

June 20, 2012 Research and Development Analytical Solutions Inc, Metanomics Health, PMG Research, Quintiles, Scripps Research Institute, Tergus Pharma

Quintiles sets up Chinese HQ, plus updates from BMS/Scripps, Metanomics Health, Inclinix/PMG and Tergus Pharma.
News
EMA HQ

EMA clarifies antibodies development

June 20, 2012 Manufacturing and Production, Research and Development, Sales and Marketing CMPHU, EMA, RA, antibodies

European regulators have issued final guidance on how pharma manufacturers should develop drugs containing monoclonal antibodies. Typically used in treatments …
News

Merck KGaA confirms leadership team appointments

June 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMD Serono, Merck KGaA, Serono

The subsidiary of Merck KGaA named EMD Serono has announced several appointments to its leadership team. The appointments include: Allene …
Appointment
Roche image

Roche signs research deal on autism spectrum disorders

June 19, 2012 Research and Development, Sales and Marketing ASD, FXS, Roche, Seaside Therapeutics, asperger's, autism

Roche has signed an agreement with Seaside Therapeutics to develop new treatments for autism and other neurodevelopmental conditions such as …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026